{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:09:15Z","timestamp":1785863355230,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study investigated the association between Anti-M\u00fcllerian Hormone (AMH) and relevant metabolic parameters and assessed its predictive value in the clinical diagnosis of polycystic ovarian syndrome (PCOS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 421 women aged 20\u201337\u2009years were allocated to the PCOS (<jats:italic>n<\/jats:italic>\u2009=\u2009168) and control (<jats:italic>n<\/jats:italic>\u2009=\u2009253) groups, and their metabolic and hormonal parameters were compared. Spearman correlation analysis was conducted to investigate associations, binary logistic regression was used to determine PCOS risk factors, and receiver operating characteristic (ROC) curves were generated to evaluate the predictive value of AMH in diagnosing PCOS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The PCOS group demonstrated significantly higher blood lipid, luteinizing hormone (LH), and AMH levels than the control group. Glucose and lipid metabolism and hormonal disorders in the PCOS group were more significant than in the control group among individuals with and without obesity. LH, TSTO, and AMH were identified as independent risk factors for PCOS. AMH along with LH, and antral follicle count demonstrated a high predictive value for diagnosing PCOS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>AMH exhibited robust diagnostic use for identifying PCOS and could be considered a marker for screening PCOS to improve PCOS diagnostic accuracy. Attention should be paid to the effect of glucose and lipid metabolism on the hormonal and related parameters of PCOS populations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-024-01405-4","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T07:02:03Z","timestamp":1712732523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Assessing the clinical diagnostic value of anti-M\u00fcllerian hormone in polycystic ovarian syndrome and its correlation with clinical and metabolism indicators"],"prefix":"10.1186","volume":"17","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuzhi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"1405_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","volume":"92","author":"CJ Glueck","year":"2019","unstructured":"Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism. 2019;92:108\u201320.","journal-title":"Metabolism."},{"issue":"3","key":"1405_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1001\/jama.2021.19776","volume":"327","author":"K Walter","year":"2022","unstructured":"Walter K. What is polycystic ovary syndrome? JAMA. 2022;327(3):294.","journal-title":"JAMA."},{"issue":"8","key":"1405_CR3","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/oby.20213","volume":"21","author":"HJ Teede","year":"2013","unstructured":"Teede HJ, Joham AE, Paul E, et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity. 2013;21(8):1526\u201332.","journal-title":"Obesity."},{"issue":"10","key":"1405_CR4","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.3390\/nu13103526","volume":"13","author":"Z Wang","year":"2021","unstructured":"Wang Z, Groen H, Cantineau AEP, et al. Dietary intake, eating behavior, physical activity, and quality of life in infertile women with PCOS and obesity compared with non-PCOS obese controls. Nutrients. 2021;13(10):3526.","journal-title":"Nutrients."},{"issue":"6","key":"1405_CR5","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1210\/clinem\/dgac039","volume":"107","author":"MI Cedars","year":"2022","unstructured":"Cedars MI. Evaluation of female fertility-AMH and ovarian reserve testing. J Clin Endocrinol Metab. 2022;107(6):1510\u20139.","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"1405_CR6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.fertnstert.2020.09.134","volume":"114","author":"A Penzias","year":"2020","unstructured":"Penzias A, Azziz R, Bendikson K, et al. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020;114(6):1151\u20137.","journal-title":"Fertil Steril."},{"issue":"1","key":"1405_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.fertnstert.2022.10.014","volume":"119","author":"BS Harris","year":"2023","unstructured":"Harris BS, Jukic AM, Truong T, et al. Markers of ovarian reserve as predictors of future fertility. Fertil Steril. 2023;119(1):99\u2013106.","journal-title":"Fertil Steril."},{"issue":"7","key":"1405_CR8","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616\u201324.","journal-title":"Hum Reprod."},{"issue":"9","key":"1405_CR9","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1093\/humrep\/der214","volume":"26","author":"JR Mellembakken","year":"2011","unstructured":"Mellembakken JR, Berga SL, Kilen M, et al. Sustained fertility from 22 to 41 years of age in women with polycystic ovarian syndrome. Hum Reprod. 2011;26(9):2499\u2013504.","journal-title":"Hum Reprod."},{"issue":"1","key":"1405_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13048-021-00786-0","volume":"14","author":"J Du","year":"2021","unstructured":"Du J, Ruan X, Jin F, et al. Abnormalities of early folliculogenesis and serum anti-M\u00fcllerian hormone in chinese patients with polycystic ovary syndrome. J Ovarian Res. 2021;14(1):36.","journal-title":"J Ovarian Res."},{"issue":"11","key":"1405_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3109\/09513590.2014.943719","volume":"30","author":"X Tian","year":"2014","unstructured":"Tian X, Ruan X, Mueck AO, et al. Serum anti-M\u00fcllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China. Gynecol Endocrinol. 2014;30(11):836\u20139.","journal-title":"Gynecol Endocrinol."},{"key":"1405_CR12","doi-asserted-by":"publisher","first-page":"9240569","DOI":"10.1155\/2022\/9240569","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu Y, Qiao J. Association of Insulin Resistance and Elevated Androgen Levels with polycystic ovarian syndrome (PCOS): a review of literature. J Healthc Eng. 2022;2022:9240569.","journal-title":"J Healthc Eng."},{"key":"1405_CR13","doi-asserted-by":"crossref","unstructured":"Dewailly D AC, Balen A, et al. . The physiology and clinical utility of anti-Mullerian hormone in women Hum Reprod Update 2014; 20(3):370\u2013385.","DOI":"10.1093\/humupd\/dmt062"},{"key":"1405_CR14","doi-asserted-by":"publisher","first-page":"616766","DOI":"10.3389\/fendo.2020.616766","volume":"11","author":"M Capuzzo","year":"2021","unstructured":"Capuzzo M, La Marca A. Use of AMH in the differential diagnosis of Anovulatory disorders including PCOS. Front Endocrinol (Lausanne). 2021;11:616766.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"1405_CR15","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","DOI":"10.1093\/humrep\/deh098"},{"key":"1405_CR16","volume-title":"National Health Industry Standard (WS\/T428\u20132013) adult body mass judgment[S]","author":"Peoples Republic of China","year":"2013","unstructured":"Peoples Republic of China. National Health Industry Standard (WS\/T428\u20132013) adult body mass judgment[S]. North Beijing: China Standard Press; 2013."},{"issue":"12","key":"1405_CR17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/metabo11120869","volume":"11","author":"W Chen","year":"2021","unstructured":"Chen W, Pang Y. Metabolic syndrome and PCOS: pathogenesis and the role of metabolites. Metabolit. 2021;11(12):869.","journal-title":"Metabolit."},{"issue":"1","key":"1405_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-016-0523-8","volume":"40","author":"K Polak","year":"2016","unstructured":"Polak K, Czyzyk A, Simoncini T, et al. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Investig. 2016;40(1):1\u20138.","journal-title":"J Endocrinol Investig."},{"issue":"10","key":"1405_CR19","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3390\/diagnostics12102313","volume":"12","author":"E Carmina","year":"2022","unstructured":"Carmina E, Lobo RA. Comparing lean and obese PCOS in different PCOS phenotypes: evidence that the body weight is more important than the Rotterdam phenotype in influencing the metabolic status. Diagnostics. 2022;12(10):2313.","journal-title":"Diagnostics."},{"key":"1405_CR20","doi-asserted-by":"crossref","unstructured":"Bahadur A, Verma N, Mundhra R, et al. Correlation of homeostatic model assessment-insulin resistance, anti-Mullerian hormone, and BMI in the characterization of polycystic ovary syndrome. Cureus. 2021;13(6):e16047.","DOI":"10.7759\/cureus.16047"},{"issue":"6","key":"1405_CR21","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.fertnstert.2008.09.003","volume":"92","author":"TH Liou","year":"2009","unstructured":"Liou TH, Yang JH, Hsieh CH, et al. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril. 2009;92(6):1960\u20135.","journal-title":"Fertil Steril."},{"issue":"1","key":"1405_CR22","first-page":"17","volume":"18","author":"M Bani Mohammad","year":"2017","unstructured":"Bani Mohammad M, Majdi SA. Polycystic ovary syndrome (PCOS) diagnostic criteria, and AMH. Asian Pac J Cancer Prev. 2017;18(1):17\u201321.","journal-title":"Asian Pac J Cancer Prev."},{"key":"1405_CR23","doi-asserted-by":"publisher","first-page":"892125","DOI":"10.3389\/fendo.2022.892125","volume":"13","author":"F Guo","year":"2022","unstructured":"Guo F, Gong Z, Fernando T, et al. The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in Chinese population. Front Endocrinol (Lausanne). 2022;13:892125.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"7","key":"1405_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","volume":"26","author":"A Gambineri","year":"2002","unstructured":"Gambineri A, Pelusi C, Vicennati V, et al. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord. 2002;26(7):883\u201396.","journal-title":"Int J Obes Relat Metab Disord."},{"issue":"2","key":"1405_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/19396368.2020.1860155","volume":"67","author":"H Fu","year":"2021","unstructured":"Fu H, Lin Y, Deng X, et al. Correlation between anti-Mullerian hormone levels and antral follicle counts in polycystic ovary and metabolic syndromes. Syst Biol Reprod Med. 2021;67(2):112\u201320.","journal-title":"Syst Biol Reprod Med."},{"issue":"3","key":"1405_CR26","first-page":"810","volume":"102","author":"S Li","year":"2017","unstructured":"Li S, Chu Q, Ma J, et al. Discovery of novel lipid profiles in PCOS: do insulin and androgen oppositely regulate bioactive lipid production? J Clin Endocrinol Metabol. 2017;102(3):810\u201321.","journal-title":"J Clin Endocrinol Metabol."},{"issue":"6","key":"1405_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/ejendo\/lvad065","volume":"188","author":"TT Piltonen","year":"2023","unstructured":"Piltonen TT, Komsi E, Morin-Papunen LC, et al. AMH as part of the diagnostic PCOS workup in large epidemiological studies. Eur J Endocrinol. 2023;188(6):547\u201354.","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"1405_CR28","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/humrep\/dead050","volume":"38","author":"M Peign\u00e9","year":"2023","unstructured":"Peign\u00e9 M, Simon V, Pigny P, et al. Changes in circulating forms of anti-Mu\u00fcllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy. Hum Reprod. 2023;38(5):938\u201350.","journal-title":"Hum Reprod."},{"key":"1405_CR29","doi-asserted-by":"publisher","first-page":"104535","DOI":"10.1016\/j.ebiom.2023.104535","volume":"90","author":"AL Barbotin","year":"2023","unstructured":"Barbotin AL, Mimouni NEH, Kuchcinski G, et al. Hypothalamic neuroglial plasticity is regulated by anti-M\u00fcllerian hormone and disrupted in polycystic ovary syndrome. eBioMed. 2023;90:104535.","journal-title":"eBioMed."},{"issue":"22","key":"1405_CR30","doi-asserted-by":"publisher","first-page":"12507","DOI":"10.3390\/ijms222212507","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, Kunicki M, Calik-Ksepka A, et al. Anti-M\u00fcllerian hormone in pathogenesis, diagnostic and treatment of PCOS. Int J Mol Sci. 2021;22(22):12507.","journal-title":"Int J Mol Sci."},{"issue":"11","key":"1405_CR31","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1093\/humrep\/dep225","volume":"24","author":"LG Nardo","year":"2009","unstructured":"Nardo LG, Yates AP, Roberts SA, et al. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod. 2009;24(11):2917\u201323.","journal-title":"Hum Reprod."},{"issue":"8","key":"1405_CR32","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1007\/s43032-023-01195-y","volume":"30","author":"N Malhotra","year":"2023","unstructured":"Malhotra N, Mahey R, Cheluvaraju R, et al. Serum anti-Mullerian hormone (AMH) levels among different PCOS phenotypes and its correlation with clinical, endocrine, and metabolic markers of PCOS. Reprod Sci. 2023;30(8):2554\u201362.","journal-title":"Reprod Sci."},{"issue":"6","key":"1405_CR33","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/cen.14098","volume":"91","author":"J Kataoka","year":"2019","unstructured":"Kataoka J, Larsson I, Bj\u00f6rkman S, et al. Prevalence of polycystic ovary syndrome in women with severe obesity \u2013 effects of a structured weight loss programme. Clin Endocrinol. 2019;91(6):750\u20138.","journal-title":"Clin Endocrinol."},{"issue":"6","key":"1405_CR34","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981\u20131030.","journal-title":"Endocr Rev."},{"key":"1405_CR35","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.2147\/DMSO.S329108","volume":"14","author":"W Shi","year":"2021","unstructured":"Shi W, Zhao Q, Zhao X, et al. Analysis of endocrine and metabolic indexes in non-obese patients with polycystic ovary syndrome and its compare with obese patients. Diabetes Metabol Syndrome Obes: Target Therapy. 2021;14:4275\u201381.","journal-title":"Diabetes Metabol Syndrome Obes: Target Therapy."},{"issue":"7","key":"1405_CR36","doi-asserted-by":"publisher","first-page":"e14117","DOI":"10.1111\/jfbc.14117","volume":"46","author":"R Shahid","year":"2022","unstructured":"Shahid R, Iahtisham-Ul-Haq, Mahnoor, et al. Diet and lifestyle modifications for effective management of polycystic ovarian syndrome (PCOS). J Food Biochem. 2022;46(7):e14117.","journal-title":"J Food Biochem."},{"issue":"10","key":"1405_CR37","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metabol. 2023;108(10):2447\u201369.","journal-title":"J Clin Endocrinol Metabol."},{"issue":"5","key":"1405_CR38","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/humupd\/dmu020","volume":"20","author":"SL Broer","year":"2014","unstructured":"Broer SL, Broekmans FJ, Laven JS, et al. Anti-M\u00fcllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20(5):688\u2013701.","journal-title":"Hum Reprod Update."},{"issue":"6","key":"1405_CR39","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/humupd\/dmu062","volume":"21","author":"S Iliodromiti","year":"2015","unstructured":"Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-M\u00fcllerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update. 2015;21(6):698\u2013710.","journal-title":"Hum Reprod Update."},{"issue":"3","key":"1405_CR40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4158\/EP15903.OR","volume":"22","author":"E Carmina","year":"2016","unstructured":"Carmina E, Campagna AM, Fruzzetti F, et al. Amh measurement versus ovarian ultrasound in the diagnosis of polycystic ovary syndrome in different phenotypes. Endocr Pract. 2016;22(3):287\u201393.","journal-title":"Endocr Pract."}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01405-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-024-01405-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01405-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T07:08:32Z","timestamp":1712732912000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-024-01405-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1405"],"URL":"https:\/\/doi.org\/10.1186\/s13048-024-01405-4","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,10]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}